S
X8604239); Cancer, liver (f; JLH); Cancer, skin (1; PH2; X8604239); Cancer, stomach (f; PH2);
Cancer, uterus (f; JLH); Candida (1; DAA); Cardiopathy (f; PNC); Chickenpox (f; PED); Childbirth
(f; DAA); Congestion (f; DAA); Constipation (1; HHB; PH2; PNC; WO2); Cough (f; PH2);
Dermatosis (f; PNC); Dysmenorrhea (f; DAA; PNC); Dystocia (f; DAA); Edema (1; WO3);
Escherichia (1; DAA); Fever (f; DAA; PED; PNC); Fungus (1; DAA); Hepatosis (f; JLH; PED);
High Cholesterol (1; HHB); Induration (f; JLH); Infection (1; DAA); Inflammation (1; JLH; PNC;
WO3; X8987908); Insomnia (1; WO2; WO3); Ischemia (1; X8425843); Measles (f; PNC); Metr-
orrhagia (f; HHB); Mycosis (1; DAA); Nervousness (1; WO2); Neurosis (1; X8425843); Pain (1;
PH2; WO3); Paralysis (f; HHB); Pemphigus (f; DAA); Pneumonia (f; DAA; HHB; PH2); Rheu-
matism (f; HHB); Scabies (f; PH2); Swelling (1; WO3); Thrombosis (1; X11243195); Tumor (1;
PH2; X8604239); Uterosis (f; DAA); Water Retention (f; PNC); Worm (f; DAA); Wound (f; DAA;
PH2; PNC); Yeast (1; DAA).Dosages (Safflower) — 1 g flower in tea to 3 ×/day (HHB); 1–2 tsp fresh flower (PED); 2–3 g
dry flower (PED); 3 g dry flower:15 ml alcohol/15 ml water (PED).Contraindications, Interactions, and Side Effects (Safflower) — Class 2b, 2d. Contraindicated
in patients with hemorrhagic disease or peptic ulcers. Notice: abortifacient, emmenagogue, and
uterostimulant. May prolong blood coagulation time (AHP). “Hazards and/or side effects not known
for proper therapeutic dosages” (PH2). Not covered by Commission E.SAFFRON (Crocus sativus L.) ++Activities (Saffron) — Abortifacient (2; PHR; PH2); Analgesic (f; APA; CRC; MAD); Anti-
depressant (f; PNC); Antidote (f; MAD); Antiedemic (1; APA); Antihysteric (f; CRC); Antiox-
idant (1; PR14:149); Antiradicular (1; PR14:149); Antiseptic (f; CRC); Antispasmodic (f; APA;